Navidea Completes Sale Of North American Rights Of Lymphoseek To Cardinal Health Post author:Sam Post published:March 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>Provention Bio</b> Secures $28.4 Million Founding Financing To Fund Development Targeting The Interception And Prevention Of Immune-Mediated Disease June 25, 2017 Idera, Biocryst Tie the Knot and Transform Into a Rare Disease Pharma January 21, 2018 Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials March 4, 2018
<b>Provention Bio</b> Secures $28.4 Million Founding Financing To Fund Development Targeting The Interception And Prevention Of Immune-Mediated Disease June 25, 2017